Recent studies into retatruptide peptide demonstrate notable outlook for managing excess body and type 2 disease. The compound, a dual activator of GLP-1 receptor and GIP receptor, looks to offer improved weight reduction and blood sugar regulation compared existing treatments. Further clinical trials are needed to completely determine its safet… Read More